Pricing

Edesa Biotech Inc (EDSA)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
CEO:
Pardeep Nijhawan
Employees:
20
100 SPY COURT, MARKHAM, A6, L3R 5H6
(905) 475-1234
    Formally known as:
  • Stellar Biotechnologies Inc
  • STELLAR BIOTECHNOLOGIES INC ORD
Stock Split History
DateRatio
2015-09-02 1:10
2018-05-07 1:7
2023-10-11 1:7
Edesa Biotech, Inc. engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients. EB01, a topical treatment for chronic allergic contact dermatitis, is also in Phase 2B clinical study.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available